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1. Introduction  
Chitin and chitosan are an important family of linear polysaccharides consisting of varying 
amounts of ǃ-(1→4)-linked 2-acetamido-2-deoxy-ǃ-D-glucopyranose (GlcNAc) and 2-
amino-2-deoxy-ǃ-D-glucopyranose (GlcN) units (Muzzarelli, 1973; Roberts, 1992). Chitin 
samples contain a high content of GlcNAc units; hence, they are insoluble in water and 
common organic solvents. On the other hand, they dissolve only in solvents such as N,N-
dimethylacetamide, hexafluoroacetone or hexafluoro-2-propanol (Pillai et al., 2009; Austin, 
1988; Kurita, 2001). When the degree of N-acetylation (defined as the average number of  
N-acetyl-D-glucosamine units per 100 monomers expressed as a percentage) is less than 
50%, chitin becomes soluble in aqueous acidic solutions (pH < 6.0) and is called chitosan 
(Pillai et al., 2009). This means that the term “chitosan” represents a group of fully and 
partially deacetylated chitins, but a rigid nomenclature with respect to the degree of N-
deacetylation between chitin and chitosan has not been established (Ravi Kumar, 2000). 
Some authors consider that chitosan is a polysaccharide containing at least 60% GlcN 
residues (Aiba, 1992). According to the nomenclature proposed by the European Chitin 
Society (EUCHIS) (Roberts, 2007), chitin and chitosan should be classified on the basis of 
their insolubility and solubility in 0.1 M acetic acid; the insoluble material is called chitin, 
whereas the soluble one is chitosan. The structures of “ideal” chitin and “ideal” chitosan, 
and the “real“ structures of these compounds are presented in Figure 1. 
Chitin is the second most abundant polysaccharide (next to cellulose) synthesized by a great 
number of living organisms, serving in many functions where reinforcement and strength 
are required (Muzzarelli et al., 1986). In nature, chitin is found as structural components in 
the exoskeleton of arthropods or in the cell walls of fungi and yeast. It is also produced by a 
number of other living organisms in the lower plant and animal kingdoms. It has been 
www.intechopen.com
 , Biomedical Engineering, Trends in Materials Science 
 
26 
estimated that 1010–1012 tons of chitin are biosynthesized each year (Percot et al., 2003). 
Unlike chitin, chitosan is produced only by some fungi from the family Mucoraceae (Roberts, 
1998). Industrially, chitosan is usually produced by de-N-acetylation of chitin. The various 
industrial sources of chitin (ǂ-, ǃ- and Ǆ-chitin) (Roberts, 1992; Tolaimate et al., 2003; 
Synowiecki & Al-Khateeb, 2003), as well as the processes and conditions under which this 
polymer is prepared (Al Sagheer, 2009; Manni et al., 2010; Das & Ganesh, 2010; Chaussard & 
Domard, 2004), cause the physical and chemical properties of chitosan preparations to vary 
(Rinaudo, 2006; Tolaimate et al., 2003; Domard, 2010).  
 
 
Fig. 1. The chemical structures of chitin and chitosan 
Chitin and chitosan have great economic value because of their versatile biological activities 
such as biocompatibility, biodegradability, non-toxicity and adsorptive abilities, as well as 
chemical applications, mainly in the medical and pharmaceutical fields (Ravi Kumar, 2000; 
Rinaudo, 2006; Murugan & Ramakrishna, 2004; Yadav & Bhise, 2004; Aranaz et al., 2009; 
Ravi Kumar et al. 2004; Di Martino et al., 2005; Krajewska, 2004; Muzzarelli & Muzzarelli, 
2005). The biological properties of these compounds depend closely on their 
physicochemical parameters, especially their solubility in water and other commonly used 
solvents. Most of the characteristic properties of chitosan are strictly related to its weight-
averaged molecular weight (MW) and the high content of glucosamine residues containing 
primary amino groups (Aranaz et al., 2009). In comparison to chitosan, chitin, being a highly 
insoluble and chemically rather unreactive material, has far fewer applications. By 
chemically modifying the primary amino and free hydroxyl groups of chitin and chitosan, 
their solubility in water and organic solvents can be improved (e.g. Zhong et al., 2007; Xie et 
al., 2007; Jeong et al. 2008), thereby increasing their range of biomedical applications (e.g. 
Kurita, 2001; Rinaudo, 2006; Alves & Mano, 2008).  
Chitin/chitosan based materials with different structures show different biological 
activities, and not all the biological activities were found in one kind of chitin/chitosan 
material  (Xia et al., 2010). Knowledge of the microstructure of chitin and chitosan samples is 
thus essential for an understanding of the structure–property–activity relationships, and 
special emphasis in this respect should be placed on the chitin/chitosans used in biomedical 
applications (Aranaz et al., 2009; Xia et al., 2010; Weinhold et al. 2009; ASTM. F2103-01, 2001; 
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ASTM. F2260-03, 2003; ASTM. WK965, 2003; Struszczyk & Struszczyk, 2007; Kean & 
Thanou, 2010).  
The aim of this book chapter is to highlight the relationship between the chemical structure 
and physicochemical properties of chitin- /chitosan-based materials in the context of their 
biomedical activity. Special emphasis will be placed on the influence of the weight-averaged 
molecular weight, degree of N-acetylation and the types of chemical modification on the 
biomedical activity of chitin-/chitosan-based materials. A strategy for improving the 
characterization of chitosan for sustainable biomedical applications will also be presented.  
2. Biomedical activity of chitin/chitosan samples differentiated on the basis 
of weight-averaged molecular weight (MW) 
The range of chitin/chitosan molecular weight is extensive (from several to more than 
thousands of kDa) and is thus divided into three categories: low-molecular-weight chitosan 
(LMWC), medium-molecular-weight chitosan (MMWC) and high-molecular-weight 
chitosan (HMWC) (Harish Prashanth & Tharanathan, 2007; Lin et al., 2009; Sun et al., 2009). 
As a consequence of increasing MW, some physicochemical and biological properties of 






unpredictable effect  
Density of chitosan solution 
(Khan et al., 2003) 
Solubility in water, 
permeation into the cell 
nucleus, antioxidant activity 
(Aranaz et al., 2009) 
Biodegradability (Zhang & 
Neau, 2001) 
pH, surface tension, 
and conductivity of 
chitosan solutions 
(Khan et al., 2003) 
Viscosity of a chitosan 
solution (Khan et al., 2003) 
Adsorption to fat droplets 
(Aranaz et al., 2009) 
Table 1. The influence of molecular weight on some properties of chitosan and its solutions  
Depending on the intended use, specific polymeric or oligomeric forms of chitin/chitosan 
are required. For some medical and pharmaceutical applications LMWC and 
chitooligosaccharides (COS) are more suitable. The exact product can be obtained by the 
enzymatic or chemical hydrolysis of polymer chains (Aranaz et al., 2009; Zhang et al., 2010b; 
Aam et al., 2010).  
2.1 Drug delivery  
One of the potential applications of chitin/chitosan products is a drug delivery system 
(nasal, oral, transdermal, etc.). Depending on the drug and its destination, a chitosan matrix 
can assume various forms: hydrogels, tablets, microspheres, films, nanoparticles, beads, 
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granules (Singh & Ray, 2000; Aranaz et al., 2009; Patel, 2006): everything serves a purpose to 
control drug release. Because they are better soluble in water, maintain a low viscosity with 
increasing concentration, and are derivatized more easily and faster, chitooligosaccharides 
appear to be more suitable as an injection material (Boesel et al., 2009). In the literature the 
expression “water-soluble chitosan” (WSC) is used to describe both LMWC and COS (Chae 
et al., 2005; Wang et al., 2007). WSC with a molecular weight range between 3.5 and 15.8 kDa 
was tested as a carrier for protein delivery (Wang et al., 2007). It was found that by 
increasing MW, the loading efficiency of a model protein (bovine serum albumin BSA) 
increased from 8%to 48% for MW from 3.5 to 6.3 kDa but only by a few percent for MW = 15.8 
kDa. The BSA release rate decreased very quickly up to 6.3 kDa, but then only slightly to 
15.8 kDa. The results of this and other studies confirm that WSC nanoparticles are suitable 
for delivering protein drugs (Wang et al., 2007; Zhang et al., 2010a). There are also several 
studies relating the MW effect to the characteristics of chitosan microspheres used as drug 
carriers (Nair et al., 2009; Sun et al., 2009). The aim of one of them was to test encapsulation 
with three different chitosans (40 kDa, 480 kDa, 850 kDa) for nasal methotrexate (MTX) 
administration (Sun et al., 2009). These authors concluded that MMWC microspheres have 
the best characteristics: the strongest mucoadhesive properties, as well as flowability and 
drug release in a controlled manner. In the case of LMWC drug release, control and 
mucoadhesion properties were poor. The disadvantages of HMWC microspheres were poor 
flowability and a tendency to aggregate. These results are in agreement with Gupta & 
Jabrail, who found that microspheres containing MMWC showed the best control of drug 
(nonsteroidal contraceptive - centchroman) release (Gupta & Jabrail, 2007). The effect of 
molecular weight on drug loading and drug release of drug-loaded chitosan microspheres 
was investigated using ketoprofen as a model drug (Genta et al., 1998). Comparing 
chitosans of 70 kDa, 750 kDa, and 2000 kDa, Genta et al. showed that a good ketoprofen 
content, an encapsulation efficiency independent of the polymer/drug ratio, and good 
control of drug release were achieved for microspheres composed of HMWC/LMWC (1:2 
w/w). The main purpose of another study was to investigate the chitosan MW effect on the 
formation and properties of pellets consisting of acetaminophen (model drug), chitosan, 
sodium alginate, dibasic calcium phosphate dehydrate and microcrystalline cellulose 
(Charoenthai et al., 2007). The influence of two samples of chitosans with different 
molecular weights (190 and 490 kDa) was compared. It was demonstrated that the 
characteristics of pellets, including shape, size, crushing force and speed of drug release, 
depend closely on chitosan MW. Charoenthai et al. showed that LMWC had better pellet-
forming properties (diameter, sphericity) and guaranteed drug release control. The effect of 
the molecular weight of four different samples of chitosan (160, 580, 1350, 1930 kDa) on the 
efficacy of two antibiotics (tobramycin and ofloxacin) used during external ocular infections 
was investigated over time by Felt et al. (Felt et al., 2001). The antibiotic content in tears was 
found to increase when HMWC was employed as compared to the controls and samples 
with a lower molecular weight of chitosan. The antibiotic efficacy of ofloxacin was also 
higher when HMWC was used, whereas tobramycin was independent of MW. 
The correlation between the molecular weight of chitosan and its interaction with different 
cell membranes was also tested (Yang et al., 2002; Chae et al. 2005). This information is very 
useful for the design of new drugs based on chitosan. Chae et al. investigated water soluble 
chitosan transport through a Caco-2 cell layer (in vitro) and intestinal absorption (in vivo) 
after the oral administration of fluorescence-labelled samples (Chae et al. 2005). It was 
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shown that intestinal absorption is molecular-weight-dependent and increases with 
decreasing chitosan MW (more than 20 times, comparing WSC samples with molecular 
weights of 3.8 kDa and 230 kDa). The same tendency was observed with respect to 
permeation through a Caco-2 cell layer – the lower the MW, the better the penetration. The 
interesting problem is the interaction of chitosan with the lipid bilayer. Yang et al. showed 
that LMWC (4.2 kDa) could destabilize a cell membrane at neutral pH (Yang et al., 2002).  
Sometimes in order to increase human immunity, the lactic acid bacteria present in food can 
be helpful. They should be delivered to the colon, but the problem is not to kill these 
bacteria in extreme gastric conditions, or during the storage of food in the refrigerator. 
Microencapsulation offers a solution. Lee et al. investigated the survival of Lactobacillus 
bulgaricus KFRI 673 in alginate microparticles coated with chitosans of different molecular 
weights (Lee et al., 2004b). The experiment was carried out in simulated gastric and 
intestinal juices at 37°C, and in skimmed milk at 4° and 22°C. They demonstrated that with 
increasing chitosan MW its protective ability towards gastric juices also increases. During 
storage at 4°C there was no difference between the stabilities of free and microencapsulated 
bacterial cells, but at 22°C the higher the molecular weight of the chitosan, the better the 
protection afforded. HMWC can be successfully used as a coating agent for alginate 
microparticles. Another example of the protection of the intestinal microbial flora is to 
deliver prebiotic agents. For this purpose chitooligosaccharides are much more useful (Lee 
et al., 2002). The influence of chitosan molecular weight on the minimum inhibitory 
concentration (MIC) was tested against bifidobacteria and lactic acid bacteria, and on the cell 
growth of the same microbes. It was shown that fully deacetyleted COS with a 
depolimerization degree of DP 2-8 exhibited a stimulatory effect on Bifidobacterium bifidium 
(0.1-0.5%) and Lactobacillus casei, and Lactobacillus brevis (0.1%), whereas chitosan in 
polymeric form displayed antimicrobial activity even at a very low concentration (0.078-
0.31%). 
2.2 Antimicrobial activity 
In comparison to the prebiotic activity of chitin/chitosans, their antimicrobial properties are 
decidedly more often discussed. The antimicrobial activity of chitosans varies depending on 
their physical properties. These polymers can be used against a broad spectrum of target 
organisms like bacteria, fungi, viruses or algae (Chirkov, 2002; Rabea et al., 2003; Tikhonov 
et al., 2006; Visnova & Vavrikova, 2008; Goy et al., 2009). The significant influence of 
molecular weight on this activity has been demonstrated, but the type of microorganism 
also plays a significant role. For such investigations Escherichia coli (Gram-negative) and 
Bacillus cereus (Gram-positive) are often used (Babiker, 2002; Vishu Kumar et al., 2005; Kittur 
et al., 2005; Fernandes et al., 2009). Native chitosan, LMWC, COS, and monomers all 
displayed an inhibitory effect against them. Vishu Kumar et al. demonstrated the better 
activity of a chito-oligomeric-monomeric mixture (with high DP) compared with native 
chitosan and monomers (Vishu Kumar et al., 2005). Although E. coli is Gram-negative and B. 
cereus is Gram-positive, and the bactericidal mechanism is different in each case, the 
influence of chitosan molecular weight was similar. This concurred with the results obtained 
by Kittur et al. (Kittur et al., 2005). They found the COS-monomeric mixture more efficient 
against both bacteria than native chitosan, and that in the case of B. cereus this effect was 
stronger still. It was interesting in both studies that GlcN showed only slight bacterial 
growth inhibition, whereas GlcNAc did not display any activity. Among the chitooligomers, 
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the antibacterial effect increased from dimer to hexamer (Vishu Kumar et al., 2005; Kittur et 
al., 2005). Fernandes et al. investigated the mechanism of chitosan antibacterial activity 
against vegetative and resistant forms of B. cereus using atomic force microscopy imaging 
and nanoindentation (Fernandes et al., 2009). They found that HMWC surrounded the 
bacterial cells. The polymer layer that formed became a mechanical barrier preventing the 
uptake of nutrients, subsequently leading to the death of the vegetative form, whereas the 
spores remained unaffected. Chitooligosaccharides caused visible damage to vegetative 
cells, but were unable to destroy the spores. In another study, gluten peptides were 
conjugated with HMWC and LMWC, then tested for antibacterial activity against E. coli 
(Babiker, 2002). Bactericidal activity of the gluten peptide-chitosan conjugates was observed 
when both types of chitosan were used, but the presence of HMWC in a conjugate made this 
more active, especially at low temperatures. Atomic force spectroscopy was also used to 
investigate the molecular weight dependency of the antibacterial effect of chitosans, but this 
time against Escherichia coli and Staphylococcus aureus (Eaton et al., 2008). These studies also 
allowed the response strategies used by Gram-negative and Gram-positive bacteria to be 
compared. In the case of E. coli antibacterial activity was better with LMWC than with 
HMWC. This is the result of the ready penetration of the Gram-negative cell wall by 
oligomers. Gram-positive bacteria have an intrinsically different cell wall structure. In this 
case the formation of a chitosan polymer layer preventing nutrient absorption is preferred, 
and HMWC displayed better antibacterial activity against S. aureus. Lin et al. (Lin et al., 
2009) reported similar observations: decreasing the chitosan molecular weight was 
conducive to growth inhibition of E. coli, but not of S. aureus. They also demonstrated the 
existence of an intraspecific diversity in sensitivity toward LMWC, which could explain the 
discrepancies appearing in some studies. They examined the different enzymes used to 
obtain LMWC, which significantly affects molecular size distribution. Comprehensive 
studies comparing antibacterial activity against many different microorganisms have also 
been carried out (Gerasimenko et al., 2004; Park et al., 2004a, Fernandes et al., 2010). 
Park et al. examined the antibacterial activity of hetero-chitosans (with different degrees of 
acetylation) and their oligosaccharides (5-10 kDa, 1-5 kDa, and <1 kDa) against three Gram-
negative (Escherichia coli, Salmonella typhimurium, Pseudomonas earuginosa) and five Gram-
positive bacteria (Bacillus subtilis, Bacillus cereus, Staphylococcus epidermidis, Staphylococcus 
aureus, Micrococcus luteus) (Park et al., 2004). Hetero-chitosans inhibited the growth of all 
bacteria, but the efficiency of this process additionally depended on the microorganism and 
DA. The inhibitory effect of hetero-COSs was lower in comparison to the activity of hetero-
chitosans. The efficiency of inhibition was found to be higher for Gram-positive than for 
Gram-negative bacteria. The potential antimicrobial activities of chitosans with different 
molecular weights were tested in the context of their use in textile finishing so as to prevent 
(or treat) skin disorders (Fernandes et al., 2010). For these investigations six skin-borne 
miscroorganisms (three Gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, two Gram-positive bacteria: Staphylococcus aureus, Staphylococcus 
epidermidids, and the fungus Candida albicans), three chitosans (average 628, 591, and 107 
kDa), and two mixtures of chitooligosaccharides (<5, <3 kDa) were chosen. The sensitivity of 
all Gram-negative bacteria increased with decreasing chitosan molecular weight. The 
opposite effect was observed with the fungus and the Gram-positive bacteria, although in 
the latter case the trend was not so distinct. The results of many investigations indicate that 
low molecular weight chitosans could be universal antimicrobial agents against all types of 
bacteria and fungi (Gerasimenko et al., 2004; Tikhonov et al., 2006).  
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2.3 Antitumour properties 
In some medical applications of chitin/chitosan, as antitumour compounds, for example, 
their degradation products are preferred, as they have a lower viscosity and a better 
solubility in water. The antitumour activity of chitin/chitosan is manifested by the 
stimulation of the immune system (production of lymphokines, including interleukins 1 and 
2,  stimulation of NK, etc.) (Qin et al., 2002a; Jeon & Kim, 2002; Maeda & Kimura, 2004). Jeon 
& Kim tested the antitumour activity of three kinds of COSs (high molecular weight ranging 
from 6.5 to 12 kDa – HMWCOS, medium molecular weight ranging from 1.5 to 5.5 kDa - 
MMWCOS, and low molecular weight ranging from 0.5 to 1.4 kDa – LMWCOS) against 
Sarcoma 180 solid (S180) and Uterine cervix carcinoma No. 14 (U14) (Jeon & Kim, 2002). The 
efficiency of tumour growth inhibition for both types of tumour cells in mice was best in the 
case of MMWCOS. There are many reports of S180 tumour cells being used for testing the 
antitumour activity of chitosan (Qin et al., 2002a; Qin et al., 2004; Maeda & Kimura, 2004). 
Maeda & Kimura investigated the antitumour effect of three water-soluble low molecular 
weight chitosans (21 kDa, 46 kDa, 130 kDa) and various doses of 650 kDa chitosan in 
sarcoma 180-bearing mice (Maeda & Kimura, 2004). They found that LMWC (21 and 46 kDa) 
and also smaller oligosaccharides could activate the intestinal immune system of animals, 
thus preventing tumour growth. But no antitumour effect was observed after the oral 
administration of chitosan samples, even of low molecular weight (46 kDa). The same 
authors confirmed that high molecular weight chitosan (650 kDa) prevents the adverse 
reactions of some cancer chemotherapeutic drugs. Qin et al. also tested the antitumour 
activity of LMWC against sarcoma 180, but they came to the opposite conclusions. They 
noted that oral administration of LMW chitosan decreases the weight of the tumour (Qin et 
al., 2002a; Qin et al., 2004), although administration by intraperitoneal injection led to a 
higher inhibitory rate (Qin et al., 2004). It was reported the higher the MW of LMWC, the 
better the inhibitory tumour effect (Qin et al., 2002a). The introduction of acidic groups as a 
result of chitosan oxidation has the opposite effect, and an increase in MW decreases 
antitumour activity (Qin et al., 2002b). The influence of LMWC and COS (including the 
pentamer, hexamer, and higher oligomers) on the growth inhibition of Ehrlich ascites 
tumour (EAT) cells and tumour-induced neovascularization was investigated (Harish 
Prashanth & Tharanathan, 2005). Based on experimental results concerning the inhibition of 
angiogenesis and the induction of apoptosis, it was confirmed that COSs seem to be more 
potent angioinhibitory and antitumour compounds. Wang et al. reported that chitin 
oligosaccharides (DP 1-6) also reduced the number of K562 cells (human 
erythromyeloblastoid leukemia cell line) (Wang et al., 2006). 
2.4 Gene delivery 
Chitosan possesses many of the properties required of gene therapy material. It is suitable as 
a base polymer for a nonviral DNA delivery system. It is important to realize that molecular 
weight is a critical factor in cytotoxicity. Investigations into this problem have shown a 
reduction in cytotoxic effect with decreasing chitosan molecular weight (Richardson et al., 
1999). For studying the relationship between structure and transfection efficiency five 
chitosans with molecular weights from 31 to 190 kDa were chosen. It was found that gene 
transfer efficacy was independent of chitosan molecular weight in the range of 31 to 170 kDa 
(Köping-Höggård et al., 2001). In another work the influence of the degree of 
polymerization in the 21-88 range (MW 4.7-33 kDa) on transfection efficiency was tested 
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(Strand et al., 2010). The maximum level was achieved for DP from 31 to 42. With increasing 
chain length, gene expression was lower and delayed. Park et al. examined COSs with 
molecular weights from 3 to 45 kDa (Park et al., 2006). To compare transgene expression 
they used HEK 293 cells with pEGFP-N1 plasmid encoding green fluorescent protein. The 
best efficiency was found for COS of molecular weight 9 kDa. There are many reports 
concerning the design of chitosan/pDNA nanoparticles for gene delivery (Bozkir & Saka, 
2004; de la Fuente et al., 2008; Centelles et al., 2008). The aim of Centelles et al. was to 
investigate the level of transgene expression mediated by three DNA-chitosan nanoparticle 
formulations differing in chitosan molecular weight (150 kDa, 400 kDa, 600kDa) (Centelles 
et al. 2008). They did not notice any effect of MW of chitosan on the long term (105 days) 
expression. In another study, nanoparticles consisting of chitosan (CS) and hyaluronic acid 
(HA) were chosen to load with pDNA (de la Fuente et al., 2008). These nanoparticles 
differed in chitosan and chitooligosaccharide molecular weight (125 kDa, 10-12 kDA 
respectively), in HA molecular weight, and in HA:CS mass ratio. Taking into account only 
the influence of chitosan it could be concluded that a lower mass promoted a better 
transfection efficiency. 
The chitosan–based delivery system is not limited to experiments with DNA. It has been 
used to transfer functionally active siRNA to HeLa cells (Techaarpornkul et al., 2010). For 
this study human cervical carcinoma cells with stable expression of enhanced green 
fluorescent protein (EGFP) were prepared. Then the gene-silencing effect of siRNA 
complexes with chitosans of different molecular weight (20, 45, 200, and 460 kDa) was 
examined. The best results were obtained with LMWC – 20 kDa. The molecular weight of 
chitosan did not affect the particle size of the CS/siRNA complex, but higher molecular 
weights did favour complex formation.  
2.5 Tissue engineering  
There is also a special place for chitin/chitosan in the field of tissue engineering. Nwe et al. 
reported that the mechanical properties of chitosan membranes deteriorated when the 
molecular weight of chitosan increased (New et al., 2009), whereas Hsu et al. maintained 
that it is precisely the high molecular weight of chitosan that gives the chitosan scaffold its 
better mechanical strength (Hsu et al., 2004a). The reduced proliferation of human skin 
fibroblast cells on a collagen/chitosan scaffold with increasing chitosan molecular weight 
was observed by Tangsadtkakun et al. (Tangsadtkakun et al., 2007), while Howling et al. 
reported that the MW of chitin and chitosan samples had no appreciable influence on the 
proliferation of tissue fibroblasts or on keratinocytes (Howling et al., 2001). The major goal 
of another study was to measure the effects of chitin/chitosan with different molecular 
weights on wound healing (Minagawa et al., 2007). They concluded that both chitin and 
chitosan oligomers and monomers are better for the acceleration of wound healing than the 
polymeric forms. Additionally, it was found that collagenase activity was greater in the 
chitosan group (the highest for GlcN), whereas it was lower for chitin and remained at the 
same level for the whole chitin group. Shelma et al. used chitin and chitosan in their 
investigations, because both possess wound healing potential (Shelma et al., 2008). They 
found that introducing chitin nanofibres considerably increased the tensile strength of 
medium molecular weight (270 kDa) chitosan films, helping this complex to be a better 
accelerator of wound healing. This stands in agreement with results concerning the tensile 
strength and arrangement of collagen fibres in the skin, obtained previously by Cho et al. 
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(Cho et al., 1999). They demonstrated the better efficacy of water-soluble chitin in wound 
healing in comparison to chitin and chitosan samples. 
2.6 The hypocholesterolemic effect 
There are also studies concerning the role of chitosan in reducing the total cholesterol level, 
and the influence of molecular weight on this was tested. The purpose of one such study 
was to investigate the correlation between feeding chitosan (MW 120 kDa) and lipid 
metabolism in hyperlipidemic rats (Xu et al., 2007). The cholesterol-lowering effect of 
chitosan was noted. The same results were achieved by Osman et al., although they used 
HMWC (Osman et al., 2010). The hypocholesterolemic effect of chitosan samples on human 
patients has also been recorded. Jaffer & Sampalis observed a lowering of serum cholesterol 
concentration after patients were treated with LMWC (40 kDa) (Jaffer & Sampalis, 2007). 
The results of other experiments did not testify to any statistically significant reductions in 
cholesterol levels (Tapola et al., 2008). It can be concluded that chitosans with different 
molecular weights are capable of lowering cholesterol levels, although the mechanisms of 
this effect are still not clear. 
In summary, chitin/chitosan with different molecular weights have numerous potential 
applications in medicine and pharmacy. Nevertheless, taking into account the properties of 
chitin/chitosan such as toxicity, water solubility, low viscosity etc., low molecular weight 
chitosans and chitooligosaccharides would appear to be more useful for the majority of 
biomedical applications. 
3. Biomedical activity of chitin/chitosan samples differentiated with respect 
to the degree of N-acetylation (DA) 
As mentioned at the beginning of this review, chitin is insoluble in aqueous solvents 
whereas chitosan is soluble in acidic or even neutral conditions owing to the free protonable 
amino groups in the glucosamine residue. The degree of N-acetylation is therefore an 
important characteristic that influences the performance of chitin/chitosan in many of its 
applications.  
The solubility, conformation and dimensions of chitosan chains in aqueous media have been 
extensively studied as a function of the degree of acetylation (DA) (Berth et al., 1998; Berth & 
Dautzenberg, 2002; Schatz et al., 2003). Schatz et al. have proposed general laws of chitosan 
behaviour in aqueous solutions (Schatz et al., 2003; Sorlier et al., 2001; Sorlier et al., 2002):  
• at DA below 20%, chitosan exhibits the highest structural charge density. Chitosan 
displays polyelectrolyte behaviour related to long-distance intra- and intermolecular 
electrostatic interactions, which are responsible for chain expansion, high solubility and 
ionic condensation.  
• for values of DA 20-50%, hydrophilic and hydrophobic interactions are progressively 
counterbalanced.  
• for DA over 50% electrostatic interactions are essentially short-distance interactions. 
Then, hydrophobic interactions due to the increase in the acetyl group content become 
predominant.  
It was confirmed that for biomedical applications chitosan with DA 0-30% is the most useful 
(Sandford, 1984; Aranaz et al., 2009). 
The DA values of chitin/chitosan depend directly on the means of deacetylation and the 
conditions of the process. In general, chitosan is prepared by severe alkaline hydrolysis of 
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the chitin acetamide groups. Usually, sodium or potassium hydroxides are used at a 
concentration of 30-50% w/v at ~100°C. Sometimes the deacetylases isolated from certain 
bacteria and fungi are used. However, the activity of these enzymes is limited by the poor 
solubility of chitin (Martinou et al., 1998) –  this is a major factor limiting its utilization. Most 
studies and applications have been carried out with chitosan because of its greater 
versatility and superior biological properties. In addition, Howling et al. demonstrated that 
highly deacetylated chitosan is biologically more active than chitin and less deacetylated 
chitosans  (Howling  et al.,  2001). Since the majority of biological properties are related to 
the cationic behaviour of chitosan (the presence of free amino groups in the polymeric 
chain), all the below-mentioned properties depend significantly on the DA.  
Biodegradability Chitin and chitosan can be degraded by several proteases (lysozyme, papain, 
pepsin) present in the human body (Vårum et al., 1997). Biodegradation yields non-toxic 
oligosaccharides that can be assimilated or excreted (Pangburn et al., 1982).  
The rate of degradation of chitosan is very important because it affects the properties of the 
material. For example, scaffold degradation should be compatible with the rate of new 
tissue formation or be adequate for the controlled release of bioactive molecules. 
Degradation of chitosan has been shown to increase as the degree of deacetylation decreases 
(Hirano et al., 1989; Sashiwa et al., 1990; Kurita et al., 2000). Kofuji et al. investigated the 
enzymatic digestion of various chitosans by observing changes in the viscosity of a chitosan 
solution in the presence of lysozyme (Kofuji et al., 2005). They concluded that chitosan with 
a high DA tended to degrade more rapidly. However, the rates of enzymatic degradation of 
chitosan species differed, even in chitosan species with similar DA. 
Aiba et al. and Shigemasa et al. suggested that the differences in degradation are due to 
variations in the distribution of acetamide groups in the chitosan molecule caused by 
differences in deacetylation conditions. Moreover, the absence of acetyl groups results in 
very low rates of enzymatic degradation (Aiba, 1992; Shigemasa et al, 1994). Therefore, it is 
impossible to estimate the biodegradation rate from the degree of deacetylation alone.  
Finally, it should also be mentioned that the lability of chitin towards lysozyme also 
depends on its crystalline form. Kurita et al. showed that ǃ-chitin was degraded much more 
readily than ǂ-chitin owing to the weak intermolecular forces in the former (Kurita et al., 
2000).  
Biocompatibility This property depends on many parameters, although DA seems to be one 
of the most important. Orally administered chitin/chitosan can be regarded as not 
bioavailable, because they are not absorbed despite partial enzymatic degradation. The 
kinetics of enzymatic chitin/chitosan biodegradation, mentioned above, also affects 
biocompatibility. Very fast rates of degradation produce amino sugars, which can cause an 
inflammatory response. Therefore, chitosan samples with high DA can induce an acute 
inflammatory response, whereas samples with low DA can induce only a minimal response. 
In the context of biocompatibility, the toxicity of chitin/chitosan should also be mentioned: 
it seems to depend on the DA. Schipper et al. reported that chitosans with DA lower than 
35% displayed low toxicity, whereas DA above 35% caused dose-dependent toxicity 
(Schipper et al., 1996). 
Mucoadhesion Mucus serves to protect epithelial cells in the gastrointestinal and respiratory 
systems in mammals. It is composed of mucin, which is negatively charged (the presence of 
sialic acid residues). In the stomach, chitosan is positively charged owing to the acidic 
condition and interacts with mucin by electrostatic forces.  
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It has been found that a lower DA leads to an increase in charge density of the molecule and 
the adhesive properties become more relevant (He et al., 1998). Mao et al. observed a direct 
correlation between the degree of deacetylation of chitosan and adhesion (Mao et al., 2004) 
The study revealed that the smaller the increases in DA, the stronger the cell adhesion. 
Not only DA, but also the distribution of acetyl groups along the chain (random or 
blockwise) can affect the biomedical properties of chitin/chitosan as a result of changes in  
the solubility, inter-chain interactions due to H-bonds and the hydrophobic nature of the 
acetyl group (Zhang et al., 2010b).  
Because of their considerable biocompatibility, quite easily controlled biodegradability and  
mucoadhesion, chitin and chitosan have been widely employed in drug and gene delivery, 
wound healing, tissue regeneration and some other biomedical applications.  
3.1 Drug delivery 
Owing to their controlled biodegradability and good biocompatibility chitin and chitosan 
are good candidates for drug delivery vehicles. The ability of chitosan to form drug delivery 
systems is due to its cationic charge and its ability to interact with negatively charged 
polyanions. Drug delivery systems using chitosan include microspheres, nanoparticles, 
hydrogels, solutions, films and tablets depend on the delivery route. 
The selection of an ideal type of chitosan with certain properties is useful for developing 
efficient drug delivery systems, prolonging the duration of drug activity, improving 
therapeutic efficiency and reducing side effects (Aranaz et al., 2009). Kofuji et al. stated that 
the proper selection of physicochemical properties of chitosan is important for the choice of 
the appropriate chitosan as a drug delivery vehicle. Among several physicochemical 
properties, DA seems to be one of the most important (Kofuji et al., 2005). 
Gupta & Jabrail observed the influence of DA and cross-linking on the physical 
characteristics, swelling and release of centchroman-loaded chitosan microspheres (Gupta & 
Jabrai, 2006). The authors concluded that since the hydrophobicity of chitosan depends on 
the numbers of N-acetyl groups, the loading and release characteristics of chitosan matrices 
depends closely on DA. Maximum loading capacity was observed at DA 38-52%, whereas 
very high DA can induce burst release. The degree of cross-linking in chitosans is controlled 
in a similar way. The larger numbers of free amino groups at lower DA increases the degree 
of covalent cross-linking. The authors also reported that the size and surface roughness of 
the microspheres decreased with a reduction in DA. Moreover, a lower DA in chitosan 
increases the compactness of matrices and its hydrophobicity, thus controlling the degree of 
swelling and diffusivity of the drug entrapped in chitosan matrices. The value of the 
diffusion coefficient for centchroman from microspheres decreased on reducing the DA of 
chitosan  (Gupta & Jabrai, 2006). 
Chiou et al. studied the influence of different chitosans on the initial burst and drug release 
from microspheres (Chiou et al., 2001). They observed that chitosans with higher DA reduce 
the initial burst of drug release more effectively.  
Aranaz et al. summarized the relation between DA and the properties of microspheres, one 
of the most common drug delivery vehicles. A decrease in chitosan DA increases covalent 
crosslinking and the compactness and hydrophobicity of the matrices, whereas increasing 
DA reduces the size, surface roughness, swelling, loading capacity and burst release of the 
microspheres (Aranaz et al., 2009). 
www.intechopen.com
 , Biomedical Engineering, Trends in Materials Science 
 
36 
Kofuji et al. investigated the relationship between the DA and the ability of chitosan to form 
spherical gels (Kofuji et al., 2005). Chitosan with low DA was able to form a spherical gel by 
chelation with metal ions, unlike chitosan with high DA. This ability was explained by the 
larger numbers of amino groups available in polysaccharides. 
3.2 Gene delivery 
Discussed compounds forming complexes with DNA play an important role in gene 
therapy. Mumper et al. proposed a non-viral vector for a gene delivery system (Mumper et 
al., 1995). As a non-viral vector for gene delivery chitin and chitosan demonstrate some 
advantages compared to viral vectors. They do not produce endogenous recombination, 
oncogenic effects or immunological reactions (Ferber, 2001).  
The MW of chitosan and its DA are key parameters in the preparation of chitosan/pDNA 
complexes. Lavertu et al. studied several combinations of MW and DA of chitosan. They 
selected two combinations of high transfection efficiency using a chitosan of 10 kDa and a 
DA of 8 and 20% (Lavertu et al., 2006). 
Kiang et al. observed the effect of the degree of chitosan deacetylation on the efficiency of 
gene transfection in chitosan/DNA nanoparticles (Kiang et al., 2004). They suggested that 
the use of chitosan with a DA above 20% might accelerate chitosan degradation and DNA 
release, since highly deacetylated chitosan (above 80%) releases DNA very slowly.  
3.3 Tissue engineering 
Chitosan scaffolds are promising materials for the design of tissue engineered systems 
owing to their low immunogenic activity, controlled biodegradability and porous structure 
(Ho et al., 2005; Ma et al., 2003; Madihally & Howard 1999). The influence of DA on the 
structural and biological properties of chitosan scaffolds for cell culture and tissue 
engineering was studied by Tiğli & Gümüsderelioglu (Tiğli et al., 2007). These authors 
observed that the mechanical strength of chitosan was better with lower DA and that 
chitosan with lower DA favoured cell adhesion. They also observed that chitosan scaffolds 
with DA (15-25%) displayed a more regular structure in comparison to scaffolds with very 
low DA (<15%). Moreover, the lateral pore connectivity was much lower for chitosans DA 
15-25% than for scaffolds with DA <15%. Both observations were very important, because it 
is very well known that the microstructure of the matrix has an important influence on cell 
intrusion, proliferation and functioning in tissue engineering.  
Freier et al. prepared and characterized chitin and chitosan tubes for nerve regeneration 
(Freier et al., 2005). The compressive strength of these tubes was found to increase with 
decreasing of DA. 
3.4 Wound healing 
Both chitin and chitosan activate the complement system in polymorphonuclear cells, 
fibroblasts and vascular endothelial cells, thereby contributing to wound healing (Minagawa 
et al., 2007). Since all of these processes are related to the properties of the matrix 
(chitin/chitosan), they also depend on the DA (Ueno et al., 2001).  
Minagawa et al. studied the influence of chitin and chitosan with different DA, as well as 
chitin oligomers and monomers (GlcN, GlcNAc) on wound healing (Minagawa et al., 2007). 
They observed that at lower DA wound break strength was greater and that fibroblasts were 
more highly activated. 
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3.5 Antimicrobial activity 
Chitin and chitosan have been investigated as antimicrobial materials with respect to a wide 
range of target organisms like algae, bacteria, yeasts and fungi.  
Chitin and chitosan with different DA were analyzed with respect to fungi (Aspergillus 
fumigatus, Aspergillus parasiticus, Fusarium oxysporum, Candida albicans), Gram-positive 
bacteria (Staphylococcus aureus, Staphylococcus saprophyticus, Bacillus cereus, Listeria 
monocytogenes) and Gram-negative bacteria (Escherichia coli, Salmonella Typhimurium, 
Pseudomonas aeruginosa, Enterococcus faecalis, Aeromonas hydrophila, Shigella dysenteriae, Vibrio 
cholerae, Vibrio parahaemolyticus). In all cases the antimicrobial activity increased with 
decreasing DA (Andres et al., 2007; Tipparat, H. & Riyaphan, 2008; Tsai et al., 2002). 
Park et al. studied the antimicrobial activity of chitosans with different degrees of 
deacetylation against three Gram-negative bacteria and five Gram-positive bacteria and 
found that 75% deacetylated chitosan exhibited more effective antimicrobial activity than 
90% or 50% deacetylated chitosan (Park et al., 2004a). 
Three antibacterial mechanisms have been proposed:  
• ionic surface interaction resulting in wall cell leakage; 
• mRNA inhibition and protein synthesis via the penetration of chitosan into the nuclei of 
the microorganisms;  
• the formation of an external barrier chelating metals and provoking the suppression of 
essential nutrients to microbial growth. It is likely that all events occur simultaneously 
but at different intensities (Goy et al., 2009;  Helander et al., 2001; Liu et al., 2001; Roller, 
&  Covill, 1999). 
It should be mentioned that some authors have not found a clear relationship between DA and 
antimicrobial activity. They suggested that the antimicrobial activity of chitosan is dependent 
on both the chitosan and the microorganism used (Chien & Chou, 2006; Oh et al., 2001).  
3.6 Antioxidative activity 
Chitosan possesses a significant scavenging capacity against different radical species. Its 
antioxidant activity depends on the degree of deacetylation (Koryagin et al., 2006). Park et 
al. studied the abilities of chitosan samples with a DA of 50, 25 and 10% to scavenge 1,1-
diphenyl-2-picrylhydrazyl (DPPH), hydroxyl, superoxide and alkyl radicals. The results 
indicated clearly that the radical scavenging activities of hetero-chitosans depend on their 
DA. Chitosan with the lowest DA exhibited the best scavenging activity (Park et al., 2004b; 
Je & Kim, 2006).  
A similar study was performed with chitooligosaccharides. The oligosaccharide prepared 
from chitosan with DA 10% displayed the greatest radical scavenging activity (Je et al., 
2004). It was concluded that the free amino groups in chitooligosaccharides can react with 
free radicals to form stable macromolecule radicals (Xie et al., 2001).  
4. Biomedical activity of chitin-/chitosan-based materials differentiated with 
respect to chemical modification  
They are a lot of chemical methods of modification which can generate completely new 
chitin-based biofunctional materials. The most common one is graft copolymerization, 
which allows the formation of applicative derivatives by the covalent binding of a molecule, 
the graft, onto the chitosan backbone (Alves & Mano, 2008). Chitosan can also be derivatized 
by introducing a small functional group such as alkyl or carboxymethyl into its structure. 
Other chemical modifications of chitin and chitosan include phosphorylation, combination 
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of chitosan derivatives with cyclodextrins, and thiolation. In this section the most important 
applications of such modified chitin and chitosan-based materials in biomedical fields such 
as drug delivery, tissue engineering and antimicrobial agents will be discussed.  
4.1 Drug delivery 
Drug delivery has been one of the major applications of chitin and chitosan derivatives in 
recent years. The main factors that allow the use of chitin and chitosan as drug delivery 
vehicles is their biodegradability and the fact that they can be easily metabolized by certain 
human enzymes, especially lysozyme (Muzzarelli, 1997). 
There are several chitosan-based drug delivery systems prepared by different methods 
(Agnihotri et al., 2004). The usual ones are:  
• tablets – prepared by coating - sodium diclofenac, pentoxyphylline, salicylic acid; 
• capsules – prepared by capsule shell - insulin, 5-aminosalicylic acid; 
• microspheres/microparticles -prepared by emulsion cross-linking – progesterone, 
aspirin, theophylline; 
• nanoparticles – prepared by ionic gelation – ricin, bovin serum albumin; 
• beads – prepared by coacervation/precipitation – riboflavin, adriamycin; 
• films – prepared by solution casting – trypsin, testosterone, beta-oestradiol; 
• gel – prepared by cross-linking – hydrocortisone acetate, caffeine, 5-fluorouracil. 
In general, drug delivery materials can be supported via various routes, like nasal, ocular, 
oral, parenteral and transdermal. Some important applications of organ-specific drug 
delivery using chitosan derivatives are presented below.  
4.1.1 Colon-targeted drug delivery 
A chitosan-based delivery system can efficiently protect therapeutic agents from the hostile 
conditions of the upper gastrointestinal tract and release the entrapped agents, especially in 
the colon, through degradation of the glycosidic linkages of chitosan by colonic microflora 
(Hejazi & Amiji, 2003). In 1998 Lorenzo-Lamosa et al. designed microencapsulated chitosan 
microspheres for colonic drug delivery (Lorenzo-Lamosa et.al., 1998). Sodium diclofenac 
(SD), an anti-inflamantory drug, was efficiently entrapped in chitosan cores and then 
microencapsulated into EudragitL-100 and Eudragit S-100 to form a multireservoir system. 
In vitro release studies revealed that no SD was released at the gastric pH; when the 
microsphere reached the colonic environment, however, continuous release was observed 
for a variable time (8-12 h). Other derivatives – chitosan succinate and chitosan phthalate – 
were synthesized and assessed as potential matrices for colon-specific orally administered 
drug delivery applications (Aiedeh & Taha, 1999). These matrices resisted dissolution under 
acidic conditions. More recently, Jain A. and Jain S.K. reported a nanoparticular system for 
the colon-specific delivery of 5-fluorouracil (Jain & Jain, 2008). They prepared hyaluronic 
acid-coupled chitosan nanoparticles bearing 5-fluorouracil using ionotropic gelation. These 
derivatives showed enhanced cellular uptake by HT-29 colon cancer cells compared to 
uncoupled nanoparticles. Wang et al. also presented some fresh chitosan derivatives useful 
as drug delivery materials (Wang et al., 2009), e.g. a polyelectrolyte complex formed by 
sodium cellulose sulphate and chitosan as a drug carrier for colon-specific delivery.  
4.1.2 Mucosal drug delivery 
Ocular, nasal, peroral, vaginal and pulmonary mucosal surfaces are receving a great deal of 
attention as alternative routes of systemic administration. It has been shown in many 
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publications that N-trimethyl chitosan and N-carboxymethyl chitosan have a special feature 
enabling them to adhere to mucosal surfaces, which has made them some of the most useful 
chitosan derivatives for mucosal drug delivery (Lueben et al., 1996; Thanou et al., 2001; 
Jayakumar et al., 2006). More recently PEG-g-chitosan nanoparticles have been proposed as 
promising vehicles for insulin transport through the nasal mucosa (Zhang et al., 2009). Also 
not long ago, Perioli et al. prepared vaginal mucoadhesive tablets containing the 
bioadhesive polymers chitosan and polyvinylpyrrolidone in a ratio of 1:1 (Perioli et al., 
2009). Several chitosan-based nanosystems, resulting in innovative ocular nanomedicines 
with a significant impact on clinical practice, have been described by Paolicelli et al. 
(Paolicelli et al., 2009). In turn, van der Lubben et al. in a review article presented the details 
of a chitosan-based delivery system for the transmucosal administration of drugs (van der 
Lubben et al., 2001). 
4.1.3 Cancer therapy 
The concept of polymer-drug conjugates for delivering hydrophobic, small molecular drugs 
to their site of action was first propounded by Ringsdorf in 1975 (Ringsdorf, 1975). Based on 
this strategy several chitosan-anticancer drug conjugates have recently been investigated 
and successfully applied in cancer therapy. A representative example is doxorubicin-
conjugated glycol chitosan (DOX-GC) with a cis-aconityl spacer (Son et al., 2003). When 
these chitosan-based nanoparticles were systemically administered to mice they 
preferentially accumulated in the tumour tissue – this was ascribed to the EPR (enhanced 
permeability and retention) effect. n-Lauryl-carboxymethylchitosan is another example of a 
useful carrier for hydrophobic cancer drugs, developed by Miwa et al. (Miwa et al., 1998). 
These chitosan derivatives have the ability to form micelles that solubilize taxol, making it 
therapeutically more effective. More recently, Zhang et al. examined another chitosan-based 
polymeric micelle for taxol delivery in cancer therapy (Zhang et al., 2003). The results show 
that this new N-alkyl-O-sulphated chitosan can be effectively used as an potential drug 
carrier for taxol. Good antitumour activities were also exhibited by N-succinyl-chitosan 
derivatives conjugated with mitomycin C (MMC) (Kato et al., 2004). These chitosan-based 
conjugates are active against various tumours such as murine leukaemias (L1210 and P338), 
B16 melanoma, Sarcoma 180 solid tumour, murine liver metastatic tumour (M5076) and 
murine hepatic cell carcinoma (MH134). Further interesting examples of chitosan-anticancer 
drug conjugates are discussed in Tan et al. (Tan et al., 2009). 
4.1.4 Gene delivery 
Chitosan has the ability to interact ionically with negatively charged DNA to form 
polyelectrolyte complexes, which results in better DNA protection against nuclease 
degradation (Agnihotri et al. 2004). Several interesting studies describing the potential use 
of chemically modified chitosan in gene delivery have been reported. Quite a lot of them 
were focused on alkylated chitosan, mostly because of its high transfection efficiency. 
Among this class of derivatives dodecyl-chitosan has the most important application in 
DNA delivery (Liu et al., 2001a). Another example of chitosan-based gene delivery was 
studied by Mao et al. (Mao et al., 2001). They produced modified chitosan nanospheres with 
transferrin and poly (ethylene glycol) (PEG) but did not observe any significant 
enhancement in transfection. PEGylation of chitosan was also used by Zhang et al. to 
prepare chitosan-DNA complexes conjugated with alpha-methoxy-omega-succinimidyl 
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poly (ethylene glycol) (Zhang et al., 2007). As a result the gene expression was improved in 
comparison with the chitosan-DNA complex both in vitro and in vivo. More recently, 
Sajomsang et al. examined a methylated chitosan derivative/DNA complex containing 
different aromatic moieties (Sajomsang et al., 2009a). Of all the derivatives tested, N-(4-
pyridinylmethyl) chitosan (MPyMeChX) exhibited the highest transfection efficiency in 
human hepatoma cells (Huh 7 cells). Many more examples of chemically modified chitosan 
used as potential gene delivery vehicels have recently been reported by Jaykakumar 
(Jayakumar et al., 2010). 
4.1.5 Other ways of delivery 
There are many publications showing that chitin and chitosan derivatives could also be used 
for liver-, kidney- and lung-targeted delivery. For example, Kato et al. evaluated the 
potential of lactosaminated N-succinyl-chitosan (Lac-Suc) as a liver-specific drug carrier 
(Kato et al., 2001). More recently, Yang et al. prepared polyion complex micelles (PIC 
micelles), also for liver-targeted delivery (Yang et al., 2009a). These micelles were based on 
methoxy poly (ethylene glycol)-graft-chitosan and lactose-conjugated poly (ethylene glycol)-
graft-chitosan, and was prepared for the delivery of diammonium glycyrrhizinate (DG). The 
experiments showed that the lactose-conjugated PIC delivered more DG to the liver than 
conventional PIC micelles. As mentioned above, chitosan derivatives could also be used for 
lung-targeted delivery. For this purpose Yang et al. prepared chitosan-modified poly (lactic-
coglycolic acid) nanoparticles containing paclitaxel (Yang et al., 2009). The results 
demonstrated that in vitro uptake of the nanoparticles by a lung cancer cell line (A549) was 
significantly increased by chitosan modification.  
4.2 Tissue engineering 
The present generation of tissue engineering research is based on seeding cells onto a 
porous biodegradable polymer matrix. The most recently published studies in this field 
have suggested the use of scaffolds to support and organize damaged tissue. Because of 
their controlled biodegradability and porous structure, chitosan and its derivatives have 
been reported as attractive candidates for scaffolding materials. Extensive studies on the use 
of chitosan-based materials in tissue engineering were described by Kim et al. in their recent 
review paper (Kim et al., 2008). Here we present just a few examples of the various types of 
chitosan derivatives modified for these applications. The strategies for using these 
derivatives in different kinds of organs such as skin, bone cartilage, liver, nerves and blood 
vessels will also be discussed.  
4.2.1 Chitosan derivatives as tissue supporting materials 
One of the most important groups of chitosan modification used for these applications 
involves the specific recognition of cells by sugars. For example, Li et al. reported that 
chitosan bound to D- and L-fucose showed specific interactions with lectin and cells (Li et 
al., 2000). Other chitosan derivatives prepared from lactobionic acid and chitosan with 
different activating agents, such as 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) 
and N-hydroxysuccinimide (NHS), demonstrated the possibility of a synthetic extracellular 
matrix for hepatocyte attachment (Park et al., 2003). More recently, Kim et al. prepared 
mannosylated chitosan with a specific recognition for antigen-presenting cells such as B-
cells, dendritic cells and macrophages (Kim et al., 2006).  
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The devlopment of the chemical grafting of chitosan has produced a series of practically 
useful tissue supporting materials. For example, chitosan graft-polymerized onto a poly (L-
lactide) surface can be used to control the morphology and function of cells (Ding et al., 
2004). Prabaharan et al. proposed a novel poly (L-lactide)-chitosan hybrid scaffold as a tissue 
engineering material that is simultaneously a drug release carrier (Prabaharan et al., 2006). 
These hybrid foams exhibit a much greater rigidity than pure chitosan foams, indicating that 
this strategy may allow for the use of chitosan-based structures in tissue engineering 
applications. 
Another approach regarding the chemical modification of chitosan for tissue engineering 
applications has been to use electrospinning to create polymeric nanofibres. These materials 
have several useful properties such as a large specific surface area and extensive porosity. 
Chitin and chitosan nanofibres were produced, for example, by Min et al. (Min et al., 2004). 
Further investigations found that these chitosan-based nanofibres promoted the adhesion of 
chondrocyte and osteoblast cells and maintained characteristic cell morphology (Bhattarai et 
al., 2005). 
 
Tissue Types of derivatives References 
Skin 
chitosan in combination with alginate 
polyelectrolyte complex 
chitosan/collagen porous scaffold made by cross-
linking with glutaraldehyde 
Yan et al., 2000; 
 
Ma et al., 2003 
Bone 
chitosan-calcium phosphate composites such as 
beta-tricalcium phosphate) 
hydroxyapatite/chitosan materials   
Zhang & Zhang, 2002; 
 
Kawakami et al., 1992 
Cartilage 
chitosan-alginate hyaluronan scaffold  attachment 
with RGD-containing protein 
porous collagen/chitosan/glycosaminoglycan 
scaffold loaded with transforming growth factor 
TGF-ǃ1 
Hsu et al., 2004b; 
 
Lee et al., 2004a 
Liver 
chitosan complex with glycosaminoglycans 
(GAG) 
chitosan/collagen/heparin matrix 
Chupa et al., 2000; 
 
Wang et al., 2005 
Nerve 
hydroxyapatite-coated chitosan tubes with 
adsorbed laminin-1 and laminin peptides 
chitosan/gelatin composites 
Itoh et al., 2003; 
 
Cheng et al., 2003 
Blood 
vessel 
heparin-chitosan scaffolds Kratz et al., 1997 
 
Table 2. Different tissue engineering applications of chitosan derivatives 
The combination of chitosan with other materials seems to be a good opportunity for tissue 
engineering applications. Chung et al. prepared a galactosylated chitosan-based scaffold 
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combined with alginate to improve mechanical properties and biocompatibility (Chung et 
al., 2002). Sarasam & Madigally reported the effect of blending chitosan with poly(ε-
caprolactone) (Sarasam & Madihally, 2005). Chitosan matrices were also modified by Ǆ-poly 
(glutamic acid), which enabled the maximum strength to be increased in tissue engineering 
applications (Hsieh et al., 2005).  
4.2.2 Applications of chitosan derivatives for different organs 
Various types of chitosan derivatives have been used in different tissue engineering 
applications, namely, skin, bone, cartilage, liver, nerve and blood vessel tissue. Some of 
them are summarized in Table 2. 
4.3 Antimicrobial agents 
The antimicrobial activity of chitin, chitosan and their derivatives against different groups of 
microorganism, such as bacteria, yeast and fungi is considered to be one of the most 
important properties in recent years. These activities were first developed by Allan and 
Hadwiger in 1979, since then many interesting studies have been reported in this field 
(Allan & Hadwiger, 1979). Several mechanisms have been suggested as the cause of the 
inhibition of microbial cells by chitosan. One mechanism involves interaction with 
predominantly anionic components, such as lipopolysaccharides and microorganism surface 
proteins, resulting in changes in permeability, which causes cell death by inducing leakage 
of intracellular components (Helander et al., 2001). A second mechanism involves the 
inhibition of RNA and protein synthesis following permeation of the cell nucleus (Liu et al., 
2001b). Yet another option is that chitosan on the surface of the cell can form a polymer 
membrane, which prevents nutrients from entering the cell (Liu et al., 2004).  In this section 
we focus on the antibacterial and antifungal activities of some chitin and chitosan 
derivatives. 
4.3.1 Antibacterial activity of chitosan derivatives 
Many chitosan derivatives inhibit the growth of a wide range of bacteria. For example, 
Papineau et al. showed that chitosan lactate and chitosan glutamate are antagonistic 
towards Escherichia coli and Staphylococcus aureus (Papineau et al., 1991). Quaternary 
ammonium salts of chitosan, such as N,N,N-trimethylchitosan, N-propyl-N,N-
dimethylchitosan and N-furfuryl-N,N-dimethylchitosan, were also shown to be effective in 
inhibiting the growth and development of Escherichia coli, especially in acidic media (Jia et 
al., 2001). Again, Xie et al. prepared multiple-derivatized chitosan (HPCTS-g-MAS) by the 
etherification of chitosan with propylene epoxide followed by the graft copolymerization of 
sodium malate and tested its antimicrobial activities against Staphylococcus aureus and 
Escherichia coli (Xie et al., 2002). Compared with chitosan, these derivatives exhibited a better 
inhibitory effect against these two bacterial species. The antibacterial activities of water-
soluble N-alkylated disaccharide chitosan derivatives against E. coli and S. aureus were also 
investigated by Yang et al. (Yang et al., 2005). These bacteria were the most susceptible to 
cellobiose-chitosan derivatives and maltose-chitosan derivatives. More recently, Sajomsang 
et al. synthesized 17 derivatives of chitosan consisting of a variety of N-aryl substituents 
bearing either electron-donating or electron-withdrawing groups (Sajomsang et al., 2009b). 
Each of the derivatives was further quaternized using N-(3-chloro-2-hydroxypropyl) 
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trimethylammonium chloride and studied for their antibacterial activities. All the 
quaternized derivatives of chitosan displayed antibacterial activity against E. coli and S. 
aureus, as observed using the minimum inhibitory concentration (MIC) method.  
4.3.2 Antifungal activity of chitosan derivatives  
Chitosan is able to induce the in vitro growth of a number of fungi except Zygomycytes, 
which have chitosan as a component of their cell walls (Allan & Hadwiger, 1979). In 1996 
Chen et al. reported that chitosan films made in dilute acetic acid solutions are able to 
inhibit the growth of Rhodotorula rubra and Penicillium notatum by direct applications of the 
film to the colony-forming organism (Chen et al., 1996). The antimicrobial activity of 
chitosan graft copolymers against Candida albicans, Trichophyton rubrum and Trichophyton 
violaceum was also observed (Jung et al., 1999). It was shown that the number and type of 
grafted chains, as well as the pH, substantially influenced the activities examined. Very 
extensive studies investigating the antifungal activity of chitosan derivatives were carried 
out by Rabea et al. (Rabea et al., 2005). They used a radial hyphal growth bioassay of B. 
cinerea and P. grisea to assess the fungicidal activity of 24 new derivatives of chitosan (i.e., N-
alkyl, N-benzylchitosans). The results showed that all the derivatives are better fungicides 
than native chitosan. N-dodecylchitosan, N-(p-isopropylbenzyl) chitosan and N-(2,6-
dichlorobenzyl) chitosan were the most active against B. cinerea, and N-(m-nitrobenzyl) 
chitosan likewise against P. grisea. Zhong et al. prepared 12 kinds of new 
hydroxylbenzenesulphonilanide derivatives of chitosan (CS), carboxymethyl chitosan 
(CMCS) and chitosan sulphated (CSS) and evaluated their antimicrobial activities against 
five pathogenic fungi: P. asparagi, A. solani, F. oxysporum f. sp. vasinfectum and C. 
gloeosporioides (Zhong et al., 2009). All these derivatives displayed stronger antifungal 
properties than the original materials (CS, CSS and CMCS). Palma-Guerrero et al. 
demonstrated that chitosan can permeabilize the plasma membrane of Neurospora crassa and 
kills the cells in an energy-dependent manner (Vruggink, 1970). 
4.4 Other biomedical properties of chitin and chitosan derivatives 
Chitin and chitosan derivatives have a great potential to be used in other biomedical 
applications. For example, chitin and chitosan sulphates display blood anticoagulant activity 
(Whistler & Kosik, 1971; Horton & Just, 1973). Substitution of a carboxyl group at position 6 
in N-sulphonated chitosan yields a product with 23 % of the activity of heparin, and its O-
sulphonated form exhibited 45 % activity in vitro. It has also been reported that the 
anticoagulant activity of sulphonated chitosan increases with rising sulphur content in 
chitosan. These derivatives could be useful as heparinoids for artificial blood dialysis. 
Grafted chitosan materials exhibited similar properties (Li et al., 2003). It has been 
demonstrated that the permeability of chitosan membranes grafted with HEMA can be 
controlled through plasma-treatment with the potential to be used in dialysis. Another very 
important biomedical activity of chitosan derivatives was investigated by Sosa et al. (Sosa et 
al., 1991), who demonstrated that N-carboxymethylchitosan N,O-sulphate inhibits HIV-1 
replication and viral binding with CD4. Selective sulphation at O-2 and/or O-3 affords 
potent antiretroviral agents showing a much higher inhibitory effect against infection with 
the AIDS virus than that by the known 6-O-sulphated derivative (Nishimura et al., 1998). It 
was also shown that N-hexanoyl and N-octanoyl chitosan fibres can be used as haemostatic 
and anti-thrombogenic materials (Hirano, 1999). More recently, Huang et al. developed a 
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nanofibrous chitosan/PVA membrane for lipase immobilization (Huang et al. 2007). The 
results showed that this system can be used for biosensor applications.  
5. Suitable strategy for the characterization of chitin-/chitosan-based 
materials used in biomedical applications  
5.1 Standardization of MW and DA determination  
During recent decades of chitosan research, many methods have been proposed to 
determine the degree of acetylation (DA) and the weight-averaged molecular weight (MW). 
Although these are two of the most important parameters of chitosan, no standard 
technique could be established. This is due mainly to some typical drawbacks of chitosan: 
poor solubility, polyelectrolyte behaviour and its polymeric character. As a consequence of 
the lack of a standard technique, many alternative methods have been put forward to 
determine these parameters. However, their accuracy and reliability are sometimes 
questionable and often depend on sample composition. DA and MW values determined by 
different methods are sometimes scarcely comparable, and interpretation or comparison of 
these data must be done carefully. To inform the reader about the methods that can be 
applied, we will briefly discuss and summarize the techniques used and described in the 
literature. 
5.2 MW determination  
In linear polymers the polymer chains rarely have the same degree of polymerization and 
molar mass, and there is always a distribution around an average value especially in natural 
polymers (except proteins and DNA). Different average values can be defined depending on 
the statistical method that is applied. Four values, such as the number-averaged molecular 
weight MN, the weight-averaged molecular weight MW, the viscosity-averaged molecular 
weight MV, and the z-averaged molecular weight MZ are in use; one of these, MW, is the 
most important. The polydispersity of a polymer sample is defined as MW divided by MN 
and gives an indication of just how narrow the distribution is. Several techniques have been 
used over the years, often measuring just one of the values mentioned above. In modern 
times the most common technique has become size-exclusion chromatography (SEC). Apart 
from batch methods such as batch viscosity measurements (Nah & Jang, 2002), batch static 
light-scattering (SLS) measurements (Berth & Dautzenberg, 2002; Cölfen et al., 2001; 
Lamarque et al., 2005; Pa & Yu, 2001), or batch multi-angle light-scattering (MALS) 
measurements (Anthonsen et al., 1994; Chen & Tsaih, 1998; Tsaih & Chen, 1997), 
chromatography has the advantage of determining the polydispersity of the sample. The 
width of the molecular weight distribution is often the key parameter of a chitosan sample. 
The higher this distribution, the less conclusive is the observed effect of one sample due to 
the presence of several thousand different molecular weights at the same time. The reliable 
determination of the polydispersity of a sample is therefore an important requirement for 
pharmaceutical and scientific observations. 
• SEC-RI (pullulan calibration) (Hasegawa et al., 1994; Knill et al., 2005; Lin & Lin, 2003)  
• SEC-LALS (Kubota et al., 2000; Ottøy et al., 1996, 1995)  
• SEC-MALS (Tømmeraas et al., 2002; Sorlier et al., 2001; Sorlier, 2002; Berth et al., 1998; 
Lamarque et al., 2004, 2005; Schatz et al., 2003; Brugnerotto et al., 2001)  
• SEC-LALS-Vis (Weinhold et al., 2009)  
• SEC-MALS-Vis (Christensen et al., 2008)  
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Since the use of size-exclusion chromatography is commonly agreed upon, more 
controversy is present about surrounds the different detectors used online for 
chromatography. Nowadays, all the old bench methods can be applied to a chromatography 
setup such as a refractive index detector (RI), viscosity detector (Vis) and light-scattering 
detectors (single-90°, low-angle and 90° (LALS), or multi-angle with 3, 5, or up to 18 angles 
(MALS). But using only refractive index or viscosity detectors MW can only be obtained with 
reference to some standard samples (often pullulan or dextran). These values differ 
significantly from the ”real” molecular weight because chitosan coils differ in solution in 
comparison to pullulan and dextran. Absolute values can be obtained by light-scattering, 
but sample composition determines the type of light-scattering device to be used. If the 
sample is below roughly 100 000 g/mol, a single-90° is sufficient to give reliable MW values. 
If the the sample weight is much higher, scattered light underlies the angular dependence 
and a significant decrease of laser intensity is observable at a detection angle of 90°. To 
overcome this problem laser light is also detected at rather low angles (LALS) (where the 
decrease becomes negligible) or at many angles (MALS). Additionally, light-scattering 
detectors can be combined with a viscosity detector to increase information about sample 
composition as a result of the simultaneous observation of conformation (via the Mark-
Houwink plot) and branching behaviour. However, the type of light scattering device to be 
used in chitosan science (low angle vs. multi angle vs. triple detection) is still a matter of 
discussion and may be based mainly on the use of different parameters in light-scattering 
experiments in chitosan research. For a light-scattering experiment, values such as dn/dc 
(refractive index increment) and Rθ (Rayleigh ratio) must be known for the molecular weight 
analysis. If only one value is changed, for example, for an interlab comparison, the resulting 
MW values will be significantly different even for identical samples. 
 
 
Fig. 2. Variation of the dn/dc values.  
In different studies of chitosan different dn/dc values were used. The diagram (Fig. 2) 
presents values obtained at 436 nm (Wang et al. 1991) and values obtained at 633 nm 
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(Terbojevich et al., 1991; Christensen et al., 2008; Kasaai et al., 2000; Chen & Tsaih, 1998; 
Berth et al., 1998; Schatz et al., 2003) for different chitosan preparations with changing 
FA(DA). 
The reason for this change is that dn/dc enters the molecular weight calculation 
quadratically. Using, for example, dn/dc = 0.142 (Christensen et al., 2008) for calculating the 
MW of a high molecular weight chitosan sample, we obtain a molecular weight of 1098 
kg/mol. Changing the dn/dc value to 0.208 (Berth et al., 1998) for the same chromatography 
data, the MW decreases to 750 kg/mol. The use of published dn/dc values on identical data 
therefore leads to a drastic change in the molecular weight of up to 32%! Thus, comparison 
of molecular weight data obtained by light-scattering must include information about the 
dn/dc value; otherwise, a comparison will never show conformity when two different 
dn/dc’s are used. 
A similar effect can be seen by changes of Rθ. To make a light scattering detector into an 
absolute measurement device the equipment needs to be calibrated once after 
manufacturing to ensure its accuracy and functionality. This is a typical procedure and is 
often done by the manufacturer. For this calibration, a pure organic solvent with known 
Rayleigh ratio, e.g. toluene (Wyatt, 1993; Santos & Castanho, 1996) is used. Nowadays, a Rθ 
of 1.402 x 105cm-1 obtained at 90° using 632.8 nm laser light (Kaye & McDaniel, 1974) should 
be used; this is stipulated by the Federal Institute for Materials Research and Testing (BAM, 
Bundesanstalt für Materialforschung und -prüfung). However, there are still other values in 
use such as 1.3522 x 10-5cm-1 and 1.340 x 10-5cm-1 (Itakura et al., 2005). Again, to obtain 
comparable molecular weight data for interlab comparisons, information about the Rayleigh 
ratio used must be included. 
Despite these difficult conditions, it has been shown that a reliable determination of molar 
masses with acceptable deviations is possible, according to a round-robin test with four 
different polymer reference materials (Just et al., 2005). In this test, different detector devices 
were applied (low-angle and multi-angle light scattering detectors), indicating negligible 
dependencies on different instruments (especially LALS vs. MALS), different cell 
geometries, or different wavelengths of laser light. Dependencies on dn/dc values, 
inappropriate solvents and the Rayleigh ratio of toluene Rθ,toluene were excluded as they were 
prescribed by the regulations. This indicates how difficult it is to initiate a standardization of 
molecular weight determination of chitosan, even for light-scattering devices, as long as 
different dn/dc and Rθ,toluene values are being used. But it also shows that standardization in 
chitosan research might be possible in the future. 
5.3 DA determination 
For the determination of DA, up to 17 different methods have been applied in the literature. 
Considering the solubility issue of some chitin/chitosan samples, some of these methods are 
inapplicable to insoluble samples. In several methods, the samples have to be carefully 
purified to avoid any interference with the measurements. Moreover, most methods have 
several drawbacks with respect to analysis time, cost or accuracy. 
To present the problem more clearly, we will summarize these methods in two bullet lists. 
The first one contains the methods that were proposed some time ago but are hardly used 
regularly as the procedures they require are time-consuming. All the methods have the 
determination of non-absolute DA values in common. The second bullet list contains the 
more accurate methods for DA determination; thus they are used more regularly. We will 
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also indicate whether the method is suitable only for chitosan, highlighted by ”soluble 
material”, or whether it is also applicable to chitin, highlighted by ”solid material”. 
• conductometric titration (Raymond et al., 1993) (soluble material)  
• UV-VIS (Muzzarelli, 1985) (soluble material)  
• circular dichroism (Domard, 1987) (soluble material)  
• thermal analysis (Alonso et al., 1983) (solid material) 
• enzymatic hydrolysis (Nanjo et al., 1991) (soluble material)  
• picric acid assay (Neugebauer et al., 1989) (soluble material)  
• pyrolysis GC (Lal & Hayes,1984) (solid material) 
• acid hydrolysis GC (Holan et al., 1980) (solid material)  
• acid hydrolysis HPLC (Niola et al., 1993) (solid material)  
• ninhydrin test (Curotto & Aros, 1993; Prochazkova et al., 1999) (soluble material) 
• X-ray deffraction (Zhang et al., 2005) (solid material)  
Since chitosan is a natural product it may contain certain residues (protein, alkali, salt, 
astaxanthin), depending on the quality of the chitin source and the reaction conditions. 
Problems with sample contamination may arise with several methods. Residual salts may 
interfere with conductometric titration by influencing the endpoint of the titration and 
therefore shift the measured DA value. Other residues like proteins display UV activity and 
may interfere with the UV-VIS and the circular dichroism method. In 2002, the European 
Pharmacopeia proposed the UV method as a standard method for characterizing chitosan 
hydrochloride. However, Aiba et al. (Aiba, 1986) found changes in the DA values (30%, 
strong) in comparison to IR spectroscopy and colloid titration, which reflects the 
vulnerability of this method. Enzymatic hydrolysis requires non-standard enzymes, the 
activity of which must be checked beforehand, and the overall procedure is relatively time-
consuming. Together with pyrolysis, acid hydrolysis GC and acid hydrolysis HPLC need a 
100% rate for the preceding hydrolysis reaction, which cannot be checked easily. 
Furthermore, the measurement time including sample preparation is very long. The 
ninhydrin method is non-quantitative and depends on different molecular weights and 
therefore needs a calibration curve determined by a second method (Prochazkova et al., 
1999). The XRD method is affected by the lyophilization of the samples, which changes the 
original crystalline properties. In summary, the overall accuracy of the above methods may 
be directly dependent on the purity of the samples investigated, and their applicability is 
limited. Thus, they do not qualify as standard methods for DA determination. 
Let us now focus on the more important methods used for DA determination. To illustrate 
the impact in the scientific community, the number of citations is shown after each method 
(determined via Web of Science (ISI Web of Knowledge) 20th July 2010). 
• IR spectroscopy (Miya et al., 1980) (solid samples) cited 117 times.  
• 1H-NMR (Hirai et al., 1991; Vårum et al., 1991a) (soluble material) cited 176 and 203 
times, respectively.  
• 13C-NMR (Vårum et al., 1991b) (soluble material) cited 84 times.  
• solid state 13C-NMR (Saito et al., 1987; Raymond et al., 1993) (solid samples) cited  76 
times.  
• 15N-NMR (Heux et al., 2000) (soluble material) cited 49 times.  
• colloid titration (Broussignac, 1968) (soluble material) . 
The IR spectroscopy method has two main advantages: it is rather quick and can also be 
used for chitin samples as the measurement requires solid material. However, there are 
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uncertainties about the best baseline setting and the selection of peaks for analysis (amide, 
amino, hydroxyl) (de Velde & Kiekens, 2004), which results in different DA values for the 
same spectrum. This shortcoming of IR spectroscopy is shown up by very highly 
deacetylated samples, in the spectra of which the amide band is scarcely distinguishable. On 
the other hand, it gives good results with very slightly deacetylated samples, which cannot 
be measured by many other methods. A serious problem is that it does not give absolute 
values and needs to be calibrated with a direct method such as NMR (de Velde & Kiekens, 
2004). Given the number of citations, it is obvious that 1H-NMR is the favourite among the 
scientific community. With up to 200 citations, the leading position of liquid state 1H-NMR 
is reflected by the best accuracy in combination with very quick results (Fernandez-Megia et 
al., 2005). Both the Hirai method and the Vårum method yield comparable DA values 
(deviation no greater than 1 or 2% of the DA value); in addition, the Vårum method is more 
accurate as it incorporates the H1 and H2 signals. However, these authors prefer Hirai’s 
method because the Vårum method requires measurements at high temperatures and 
extends the measuring time, whereas the Hirai method can be performed at room 
temperature. The main advantage of the NMR method is the generation of absolute values 
through the simultaneous detection of deacetylated and acetylated signals. The ratio of the 
one to the other reveals the DA value without any calibration or assumptions. In contrast, 
liquid state 1H-NMR cannot be used for chitin because this technique is limited to soluble 
material and the equipment is extremely costly. Similar results can be obtained by 13C-NMR, 
solid state 13C-NMR and 15N-NMR, but these techniques extend the measurement time to 
more than one hour per sample at the least (depending on the device and conditions) and 
are, despite the good accuracy, far from becoming standard methods. Exceptionally, solid 
state 13C-NMR shows greater potential because it covers the range of 0% to 100% 
deacetylated samples. Nevertheless, NMR has become the most reliable technique for DA 
determination in recent years (Domard, 2007). It shows good repeatability and 
reproducibility of results, not only for interoperator comparisons but also for interlab 
comparisons on different NMR devices (at least, this is our experience). Beyond the scientific 
research community, the simple colloid titration method enjoys great popularity mainly due 
to its unbeatable costs. Small chitosan producing facilities typically do not have access to 
NMR equipment or simply want to avoid their expense. Although it is prone to impurities 
(alkali residues), it can be performed very quickly in even the simplest lab. Like the above-
mentioned methods it does not give absolute values and needs to be calibrated or should 
first be performed with samples of known DA. 
6. Conclusions  
Chitin and chitosan are natural aminopolysaccharides with unique structures, 
multidimensional properties, highly sophisticated functions and wide ranging applications, 
especially in the biomedical and pharmaceutical fields. Moreover, the chemical modification 
of these polymers improves their solubility in water or organic solvents, which in turn 
enhances their biological activities and raises the number of potential biomedical 
applications. Chitin and chitosan have an intrinsic structural and physicochemical 
variability because of their natural origin and the manufacturing process. Furthermore, the 
poor physicochemical characterization of the chitin-/chitosan-based products used in 
biomedical experiments makes it very difficult to compare results and to establish 
relationships between the physiological behaviour of these compounds and their properties.  
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At present, the accurate study of the properties of chitin/chitosan requires the use of well-
characterized, high-quality products. Knowledge of the microstructure of these compounds 
is essential for an understanding of structure–property–activity relationships. On the basis 
of literature data it has been possible to present in this chapter important information about 
the influence of the chemical structure and physicochemical properties of chitin-/chitosan-
based materials on their biomedical activity. This knowledge is especially important for 
biotech companies. In each of these uses, it is necessary to control the different parameters 
which influence the characteristics of chitin/chitosan so as to produce it according to the 
characteristics desired by companies. The proper adjustment of the process conditions will 
make it possible to produce chitins very similar to their native form, and to prepare 
chitosans and their derivatives with well-controlled characteristics. An understanding of 
these molecular-level details provides insights into the unknown biochemical functions of 
chitin-/chitosan-based products and helps to accelerate their future applications. 
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